Green Alpha Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Green Alpha Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$361K	Buy	43,103 +338	+0.8%	+$2.43K	0.24%	92
2026 Q2	$247K	Sell	42,765 -187	-0.4%	-$949	0.17%	93
2026 Q1	$213K	Sell	42,952 -2,708	-6%	-$13.2K	0.21%	93
2025 Q4	$213K	Buy	45,660 +4,444	+11%	+$20.1K	0.2%	101
2025 Q3	$196K	Sell	41,216 -1,690	-4%	-$5.81K	0.19%	91
2025 Q2	$133K	Sell	42,906 -4,172	-9%	-$12.4K	0.13%	99
2025 Q1	$156K	Sell	47,078 -138	-0.3%	-$485	0.17%	98
2024 Q4	$145K	Buy	47,216 +25,686	+119%	+$87.4K	0.12%	134
2024 Q3	$78.6K	Buy	+21,530	New	+$87.5K	0.06%	137

Other funds holding SOPH

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Green Alpha Advisors's SOPH Position: Q3 2026 in Review

Green Alpha Advisors increased its SOPHiA GENETICS (SOPH) stake by 0.79% in Q3 2026, buying an estimated $2.43K and bringing the position to 43,103 shares worth $361K. The position accounts for 0.24% of the portfolio, ranked #92.

Green Alpha Advisors first reported a position in SOPH in Q3 2024 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

Green Alpha Advisors held 43,103 shares of SOPHiA GENETICS worth $361K as of Q3 2026.
Green Alpha Advisors bought 338 SOPHiA GENETICS shares in Q3 2026, an estimated $2.43K.
SOPHiA GENETICS made up 0.24% of Green Alpha Advisors's portfolio in Q3 2026, its #92 holding.
Green Alpha Advisors first reported a position in SOPHiA GENETICS in Q3 2024 and has held it in 9 quarters since.
4 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.